Risk ratios for each pairwise comparison of IL-17As or IL-17RA vs IL-23 or IL-12/23 therapies at PASI 75, 90 and 100 from placebo-adjusted base-case analysis: median risk ratio (95% credible interval).
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://figshare.com/articles/dataset/Risk_ratios_for_each_pairwise_comparison_of_IL-17As_or_IL-17RA_vs_IL-23_or_IL-12_23_therapies_at_PASI_75_90_and_100_from_placebo-adjusted_base-case_analysis_median_risk_ratio_95_credible_interval_/9623924
下载链接
链接失效反馈官方服务：
资源简介：
Risk ratios for each pairwise comparison of IL-17As or IL-17RA vs IL-23 or IL-12/23 therapies at PASI 75, 90 and 100 from placebo-adjusted base-case analysis: median risk ratio (95% credible interval).
创建时间：
2019-08-14
